RCS - Diaceutics PLC - Diaceutics Announces Key Leadership Appointment

DiaceuticsAnnouncement

15/10/2024 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241015:nRSO1382Ia&default-theme=true

RNS Number : 1382I  Diaceutics PLC  15 October 2024

RNS Reach

Diaceutics Announces Key Leadership Appointment

Sandra Blake appointed Chief People Officer

Belfast and London, 15 October 2024 - Diaceutics PLC (AIM: DXRX), a leading
technology and solutions provider to the pharma and biotech industry, is
pleased to announce the appointment of Sandra Blake as Chief People Officer of
Diaceutics PLC.

Sandra has over 25 years leadership experience across Human Resources,
Marketing & Innovation in the Technology, Engineering, Banking, Insurance,
FMCG, Retail and Energy sectors.

 

Sandra has worked with companies including NatWest Group PLC, Tesco PLC,
Cadbury PLC and Kraft Foods Inc.

 

Ryan Keeling, Chief Execuitve Officer of Diaceutics commented: "Sandra brings
a wealth of operational and management experience to the Diaceutics team and I
know she will provide a significant contribution to our performance and growth
in the future."

 

Sandra Blake, Chief People Officer of Diaceutics commented: "I am honoured and
excited to take on the role of Chief People Officer at Diaceutics.  I have
followed Diaceutics' growth in recent years and am very much looking forward
to helping maximise our market opportunity by nurturing our team's growth as
we continue to drive our commercial success."

 

Enquiries:

 

 Diaceutics PLC  
 Ryan Keeling, Chief Executive Officer             Tel: +44 (0)28 9040 6500

 Nick Roberts, Chief Financial Officer             investorrelations@diaceutics.com (mailto:investorrelations@diaceutics.com)

 Canaccord Genuity Limited (Nomad & Broker)        Tel: +44 (0)20 7523 8000
 Simon Bridges, Andrew Potts, Harry Rees

 Alma Strategic Communications                     Tel: +44(0)20 3405 0205
 Caroline Forde, Kinvara Verdon                    diaceutics@almastrategic.com

 

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to
receive the right test and the right therapy to positively impact their
disease outcome. We provide the world's leading pharma and biotech companies
with an end-to-end commercialisation solution for precision medicines through
data analytics, scientific and advisory services enabled by our platform DXRX
- The Diagnostics Network®.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAUSSBRSAURAAA